Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Shikhar Tomur

Plastic and Reconstructive Surgery Dallas, TX Medical Doctor

NPI 1255836623 CMS profile 11287042

1801 Inwood Rd, Dallas, TX 75235

Open in the dashboard

General payments

$4,864

57 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Shikhar Tomur of Dallas, TX is reported in the CMS Open Payments database as having received $4,864 across 57 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,712 31
2024 General $1,137 13
2023 General $569 7
2022 General $337 4
2021 General $108 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shikhar Tomur
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Shikhar Tomur were reported at $2,712. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Shikhar Tomur Plastic and Reconstructive Surgery median Middle half National median
2019 $0 $335 $121–$1,264 $163
2020 $0 $162 $57–$417 $114
2021 $108 $245 $89–$735 $132
2022 $337 $325 $120–$932 $149
2023 $569 $343 $129–$999 $160
2024 $1,137 $390 $141–$1,085 $164
2025 $2,712 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,835 22 payments
  2. Davol Inc. $758 8 payments
  3. Mentor Worldwide LLC $662 10 payments
  4. Integra LifeSciences Corporation $267 2 payments
  5. Motiva USA, LLC $196 2 payments
  6. Galderma Laboratories, L.P. $161 2 payments
  7. Biocircuit Technologies Inc $155 1 payment
  8. Becton, Dickinson and Company $149 1 payment
  9. Acera Surgical, Inc. $144 1 payment
  10. PolyNovo North America LLC $125 1 payment
  11. Other $413 7 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,803 56 payments
  2. Travel and Lodging $61 1 payment
Products named General payments · program years 2021–2025
  1. NATRELLE SALINE-FILLED BREAST IMPLANTS $1,179 15 payments
  2. MENTOR MemoryGel Resterilizable Gel Sizer $525 9 payments
  3. Phasix Mesh Surgery $420 4 payments
  4. Phasix Mesh BD Interventional Surgery $337 4 payments
  5. BOTOX $290 2 payments
  6. Integra Recon-Skin And Wound $267 2 payments
  7. Integra Recon-Skin And Wound $267 2 payments
  8. INTEGRA DERMAL REGENERATION TEMPLATE $267 2 payments
  9. Motiva Implant Matrix $196 2 payments
  10. Integra Recon-Skin And Wound $170 1 payment
  11. Other $1,722 18 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

57 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record